Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered. Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use. The factors driving this market include increasing hospitalization rate and rise in demand for faster, safer and effective administration of drugs. The introduction of single dosage nervous system disorders, oncology and diabetes would provide opportunities for growth of this market. In 2019, the market size of Large Volume Parenteral (LVP) is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Large Volume Parenteral (LVP). This report studies the global market size of Large Volume Parenteral (LVP), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Large Volume Parenteral (LVP) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019. In global market, the following companies are covered: Ostuka Pharmaceutical Teva Pharmaceutical Industries Kelun Pharma Cook Pharmica Patheon BAG Healthcare Southwest Pharmaceutical Cook Pharmica Beximco Pharma Baxter Healthcare Corporation Market Segment by Product Type Fluid Balance Injections Therapeutic Injections Nutritious Injections Market Segment by Application Hospitals Medical Centers Others Key Regions split in this report: breakdown data for each region. United States China European Union Rest of World (Japan, Korea, India and Southeast Asia) The study objectives are: To analyze and research the Large Volume Parenteral (LVP) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast. To present the key Large Volume Parenteral (LVP) manufacturers, presenting the sales, revenue, market share, and recent development for key players. To split the breakdown data by regions, type, companies and applications To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends, drivers, influence factors in global and regions To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market In this study, the years considered to estimate the market size of Large Volume Parenteral (LVP) are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Major Manufacturers Covered in This Report 1.3 Market Segment by Type 1.3.1 Global Large Volume Parenteral (LVP) Market Size Growth Rate by Type (2019-2025) 1.3.2 Fluid Balance Injections 1.3.3 Therapeutic Injections 1.3.4 Nutritious Injections 1.4 Market Segment by Application
